Management of Acute-on-Chronic Liver Failure (ACLF)
Immediately admit your patient to the ICU, establish early contact with a transplant center, identify and treat precipitating factors aggressively, provide full organ support, and recognize that liver transplantation remains the only curative option for non-reversible ACLF. 1, 2
Immediate Priorities
ICU Admission and Transplant Center Contact
- All patients with ACLF require ICU-level monitoring and management 3, 1
- Contact a transplant center immediately upon diagnosis—do not delay this critical step 3, 2
- ACLF carries 28-day mortality of 20-45% depending on grade, making early triage decisions life-saving 1, 4
Identify the Precipitating Event
The most common triggers you must actively search for and treat:
- Bacterial infections (most common precipitant—obtain cultures immediately) 1, 5
- Severe alcohol-related hepatitis 1, 6
- Gastrointestinal bleeding 7, 4
- Drug-induced hepatotoxicity (review ALL medications, supplements, herbals) 3
- Viral hepatitis flares (check HBV, HAV, HEV serologies) 3
Essential Diagnostic Workup
Obtain these tests immediately:
- Blood work: PT/INR, Factor V, liver enzymes (AST/ALT ratio), bilirubin, creatinine, arterial ammonia, lactate, arterial blood gas 8
- Hepatic Doppler ultrasound to exclude vascular thrombosis and assess for chronic liver disease features 8
- Echocardiography if ischemic hepatitis suspected (AST > ALT, cardiac history, shock) 8
- Infection surveillance: Blood cultures, urine cultures, chest X-ray, ascitic fluid analysis if present 3, 8
- Viral serologies: HBsAg, anti-HBc IgM, IgM anti-HAV, HEV if travel history 3
Specific Therapeutic Interventions
N-Acetylcysteine (NAC)
Administer NAC regardless of etiology—this is a strong recommendation based on recent evidence. 8
For acetaminophen-induced cases: Start immediately without waiting for drug levels 8
For non-acetaminophen ACLF: NAC improves transplant-free survival (64% vs 26%) and post-transplant survival (85.7% vs 71.4%) 8
- The 2020 guidelines provide stronger evidence than older 2005 recommendations for universal NAC use
Etiology-Specific Treatments
Viral hepatitis:
- Herpes simplex virus: Start acyclovir immediately if suspected (fever, third trimester pregnancy, immunosuppression) 3, 8, 3
- Hepatitis B: Consider lamivudine or adefovir, though not proven in controlled trials for acute disease 3
Mushroom poisoning (Amanita):
- Penicillin G plus silymarin (30-40 mg/kg/day IV or oral for 3-4 days) 3
- List immediately for transplantation—often the only life-saving option 3
Drug-induced hepatotoxicity:
- Discontinue ALL non-essential medications immediately 3
- Document exact timing, doses, and ingredients of all substances taken in past year 3
Organ Support Management
Encephalopathy Management
- Grade I-II: Avoid sedation if possible; lactulose may be used but causes bowel distention 3
- Grade III-IV:
Intracranial Pressure (ICP) Management
- Consider ICP monitoring for transplant-listed patients (no consensus, but commonly done) 3
- If ICP elevation occurs: Give mannitol; hyperventilation only for acute life-threatening herniation 3
- Do NOT use corticosteroids for ICP control 3
- Short-acting barbiturates for refractory ICP 3
Hemodynamic Support
- Fluid resuscitation guided by hemodynamic monitoring 8
- Vasopressors as needed (no specific agent preference in ACLF) 8
- Consider hydrocortisone 300 mg/day if vasopressor-dependent (50% have relative adrenal insufficiency) 8
- Monitor cardiac function—both right and left ventricular dysfunction can occur 8
Mechanical Ventilation
- Protective ventilation strategies per standard ICU protocols 8
- Caution with high PEEP (>10 cmH₂O)—risk of hepatic congestion 8
Infection Prevention and Treatment
- Surveillance cultures (blood, urine, sputum) every 48-72 hours if not on prophylaxis 3
- Low threshold for starting empiric antibiotics and antifungals 3
- Prophylactic antibiotics reduce infection incidence but no proven survival benefit—decision is center-dependent 3
Prognostic Assessment
Poor prognostic indicators requiring urgent transplant evaluation:
- pH < 7.3 (acetaminophen cases) 8
- PT > 100 seconds 8
- Creatinine > 300 μmol/L 8
- Lactate > 3.5 mmol/L at 4 hours or > 3.0 mmol/L at 12 hours after resuscitation 8
- Ammonia > 100-150 μmol/L (increased intracranial hypertension risk) 8
- MELD score and CLIF-C scores guide severity stratification 8, 1
Transplant-free survival by etiology:
- 50% survival: Acetaminophen, hepatitis A, hypoxic hepatitis, pregnancy-related 8
- <25% survival: Hepatitis B, non-acetaminophen drugs, autoimmune hepatitis, Wilson disease, Budd-Chiari 8
Liver Transplantation Considerations
Liver transplantation is the only curative treatment for non-reversible ACLF. 2, 1, 5
- List urgently for patients meeting criteria 3
- ACLF grade correlates with mortality—higher grades need faster evaluation 1, 7
- Post-transplant outcomes in ACLF are acceptable with proper patient selection 1, 5
- Critical caveat: Narrow therapeutic window—patients can deteriorate rapidly or develop contraindications 4, 9
Palliative Care Integration
Consider palliative care consultation at ACLF diagnosis or ICU admission—this does NOT preclude transplant evaluation. 2
- Palliative care and transplant listing are not mutually exclusive 2
- Quality indicators show goals-of-care discussions occur too late in current practice 2
- Advanced care planning should happen early, ideally before severe decompensation 2
Common Pitfalls to Avoid
- Delaying transplant center contact—this is the most critical error
- Withholding NAC in non-acetaminophen cases—newer evidence supports universal use 8
- Using benzodiazepines for sedation—worsens encephalopathy 8
- Prophylactic hyperventilation—no benefit and may worsen cerebral hypoxia 3
- Using corticosteroids for ICP—proven ineffective 3
- Assuming transplant listing precludes palliative care—engage both simultaneously 2
- Missing occult infections—maintain high suspicion and low threshold for cultures 3, 8